Handelen Repligen - RGEN CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Spread | 0.59 | ||||||||
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.025457% | ||||||||
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | 0.003235% | ||||||||
Tijd van overnight-tarief | 21:00 (UTC) | ||||||||
Min. verhandelde hoeveelheid | 1 | ||||||||
Valuta | USD | ||||||||
Marge | 20% | ||||||||
Effectenbeurs | United States of America | ||||||||
Handelscommissie | 0% |
*Information provided by Capital.com
Repligen Corp ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 167 |
Open* | 169.46 |
1-Jaarlijkse Verandering* | 1.57% |
Dagelijks bereik* | 166.91 - 169.85 |
52 wekelijks bereik | 137.65-262.26 |
Weekgemiddelde volume (10 dagen) | 661.12K |
Gemiddeld volume (3 maanden) | 11.76M |
Marktkapitalisatie | 9.35B |
P/E Ratio | 57.04 |
Uitstaande Aandelen | 55.68M |
Omzet | 777.80M |
EPS | 2.94 |
Dividend (opbrengst %) | N/A |
Beta | 1.06 |
Volgende inkomsten datum | Jul 31, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
---|---|---|---|---|---|---|
Jun 1, 2023 | 167.00 | -0.26 | -0.16% | 167.26 | 167.61 | 162.90 |
May 31, 2023 | 167.27 | -4.12 | -2.40% | 171.39 | 171.56 | 167.24 |
May 30, 2023 | 173.25 | 1.71 | 1.00% | 171.54 | 176.37 | 170.61 |
May 26, 2023 | 170.92 | 2.26 | 1.34% | 168.66 | 173.19 | 166.45 |
May 25, 2023 | 167.79 | 1.92 | 1.16% | 165.87 | 169.94 | 164.90 |
May 24, 2023 | 165.19 | -1.55 | -0.93% | 166.74 | 166.74 | 160.33 |
May 23, 2023 | 169.88 | 3.91 | 2.36% | 165.97 | 171.67 | 165.97 |
May 22, 2023 | 166.67 | 7.77 | 4.89% | 158.90 | 167.09 | 158.29 |
May 19, 2023 | 159.14 | 2.84 | 1.82% | 156.30 | 160.18 | 156.13 |
May 18, 2023 | 156.50 | 4.59 | 3.02% | 151.91 | 156.75 | 151.71 |
May 17, 2023 | 152.85 | 1.14 | 0.75% | 151.71 | 153.64 | 149.58 |
May 16, 2023 | 151.75 | 0.84 | 0.56% | 150.91 | 152.05 | 149.30 |
May 15, 2023 | 153.92 | 3.01 | 1.99% | 150.91 | 155.74 | 149.17 |
May 12, 2023 | 151.85 | -0.46 | -0.30% | 152.31 | 153.45 | 149.42 |
May 11, 2023 | 152.17 | -1.00 | -0.65% | 153.17 | 153.73 | 150.01 |
May 10, 2023 | 154.73 | -5.75 | -3.58% | 160.48 | 160.88 | 154.51 |
May 9, 2023 | 157.80 | 2.79 | 1.80% | 155.01 | 158.13 | 153.90 |
May 8, 2023 | 156.33 | -2.57 | -1.62% | 158.90 | 160.21 | 154.90 |
May 5, 2023 | 159.93 | 1.03 | 0.65% | 158.90 | 160.50 | 154.02 |
May 4, 2023 | 157.01 | -5.44 | -3.35% | 162.45 | 162.47 | 156.06 |
Repligen Events
Tijd (UTC) (UTC) | Land | Evenement |
---|---|---|
Monday, July 31, 2023 | ||
Tijd (UTC) (UTC) 12:30 | Land US
| Evenement Q2 2023 Repligen Corp Earnings Release Q2 2023 Repligen Corp Earnings ReleaseForecast -Previous - |
Monday, October 30, 2023 | ||
Tijd (UTC) (UTC) 12:30 | Land US
| Evenement Q3 2023 Repligen Corp Earnings Release Q3 2023 Repligen Corp Earnings ReleaseForecast -Previous - |
- Jaarlijks
- Per kwartaal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Totale inkomsten | 801.536 | 670.534 | 366.26 | 270.245 | 194.032 |
Inkomsten | 801.536 | 670.534 | 366.26 | 270.245 | 194.032 |
Kosten van opbrengsten, totaal | 345.83 | 279.28 | 156.634 | 119.099 | 86.531 |
Brutowinst | 455.706 | 391.254 | 209.626 | 151.146 | 107.501 |
Totale bedrijfskosten | 576.866 | 503.298 | 296.437 | 239.812 | 168.044 |
Verkoop/Algemeen/Admin. Uitgaven, Totaal | 188.813 | 157.225 | 99.589 | 82.013 | 52.192 |
Onderzoek & Ontwikkeling | 43.936 | 34.274 | 20.182 | 19.45 | 15.821 |
Ongebruikelijke uitgaven (inkomsten) | -28.729 | 10.578 | 4 | 5.65 | 2.9 |
Bedrijfsresultaat | 224.67 | 167.236 | 69.823 | 30.433 | 25.988 |
Renteopbrengsten (-uitgaven), netto Niet-operationeel | 5.816 | -12.538 | -10.392 | -3.968 | -4.814 |
Overige, Netto | -11.346 | -1.155 | -0.214 | -0.314 | 0.262 |
Netto inkomen voor belastingen | 219.14 | 153.543 | 59.217 | 26.151 | 21.436 |
Netto inkomen na belastingen | 185.959 | 128.291 | 59.926 | 21.411 | 16.617 |
Netto inkomen voor extra. Posten | 185.959 | 128.291 | 59.926 | 21.411 | 16.617 |
Netto inkomen | 185.959 | 128.291 | 59.926 | 21.411 | 16.617 |
Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 185.959 | 128.291 | 59.926 | 21.411 | 16.617 |
Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 185.959 | 128.291 | 59.926 | 21.411 | 16.617 |
Verwaterd Netto Inkomen | 186.346 | 128.291 | 59.926 | 21.411 | 16.617 |
Verwaterd Gewogen Gemiddelde Aandelen | 57.455 | 57.264 | 53.892 | 49.206 | 45.471 |
Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 3.24334 | 2.24034 | 1.11196 | 0.43513 | 0.36544 |
Verwaterde Genormaliseerde Winst per Aandeel | 3.03077 | 2.55806 | 1.58048 | 0.77026 | 0.41488 |
Totale buitengewone posten | |||||
Depreciation / Amortization | 27.016 | 21.941 | 16.032 | 13.6 | 10.6 |
Verwateringsaanpassing | 0.387 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Totale inkomsten | 182.66 | 186.762 | 200.741 | 207.633 | 206.4 |
Inkomsten | 182.66 | 186.762 | 200.741 | 207.633 | 206.4 |
Kosten van opbrengsten, totaal | 81.845 | 90.7 | 86.514 | 86.26 | 82.356 |
Brutowinst | 100.815 | 96.062 | 114.227 | 121.373 | 124.044 |
Totale bedrijfskosten | 151.404 | 137.925 | 148.076 | 144.465 | 146.4 |
Verkoop/Algemeen/Admin. Uitgaven, Totaal | 56.17 | 53.237 | 53.643 | 54.649 | 54.3 |
Onderzoek & Ontwikkeling | 12.154 | 11.113 | 10.228 | 10.44 | 12.155 |
Ongebruikelijke uitgaven (inkomsten) | 1.235 | -17.125 | -2.309 | -6.884 | -2.411 |
Bedrijfsresultaat | 31.256 | 48.837 | 52.665 | 63.168 | 60 |
Renteopbrengsten (-uitgaven), netto Niet-operationeel | 5.216 | 3.746 | 1.848 | 0.437 | -0.215 |
Overige, Netto | -0.38 | 0.403 | -7.046 | -3.849 | -0.854 |
Netto inkomen voor belastingen | 36.092 | 52.986 | 47.467 | 59.756 | 58.931 |
Netto inkomen na belastingen | 28.829 | 48.729 | 40.405 | 49.861 | 46.964 |
Netto inkomen voor extra. Posten | 28.829 | 48.729 | 40.405 | 49.861 | 46.964 |
Netto inkomen | 28.829 | 48.729 | 40.405 | 49.861 | 46.964 |
Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 28.829 | 48.729 | 40.405 | 49.861 | 46.964 |
Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 28.829 | 48.729 | 40.405 | 49.861 | 46.964 |
Verwaterd Netto Inkomen | 28.829 | 48.729 | 40.405 | 49.861 | 47.351 |
Verwaterd Gewogen Gemiddelde Aandelen | 57.049 | 57.026 | 57.304 | 56.721 | 58.816 |
Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 0.50534 | 0.8545 | 0.7051 | 0.87906 | 0.80507 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Verwaterde Genormaliseerde Winst per Aandeel | 0.59044 | 0.63334 | 0.7303 | 0.82855 | 0.83601 |
Verwateringsaanpassing | 0 | 0 | 0 | 0.387 |
- Jaarlijks
- Per kwartaal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Totaal vlottende activa | 998.118 | 931.677 | 902.382 | 641.828 | 275.739 |
Geldmiddelen en kortetermijnbeleggingen | 623.757 | 603.814 | 717.292 | 528.392 | 193.822 |
Geldmiddelen & Equivalenten | 523.458 | 603.814 | 717.292 | 528.392 | 193.822 |
Korte Termijn Investeringen | 100.299 | ||||
Totale Vorderingen, Netto | 116.766 | 121.39 | 74.038 | 46.391 | 36.596 |
Accounts Receivable - Trade, Net | 116.247 | 117.42 | 71.257 | 43.068 | 33.015 |
Total Inventory | 238.277 | 184.494 | 95.025 | 54.832 | 42.263 |
Prepaid Expenses | 1.909 | 2.713 | 1.936 | 0.08 | 0.629 |
Other Current Assets, Total | 17.409 | 19.266 | 14.091 | 12.133 | 2.429 |
Total Assets | 2524.66 | 2358.35 | 1902.89 | 1400.11 | 774.621 |
Property/Plant/Equipment, Total - Net | 315.696 | 226.523 | 92.046 | 74.162 | 32.18 |
Property/Plant/Equipment, Total - Gross | 408.003 | 297.24 | 141.102 | 109.541 | 60.492 |
Accumulated Depreciation, Total | -92.307 | -70.717 | -49.056 | -35.379 | -28.312 |
Goodwill, Net | 855.513 | 860.362 | 618.305 | 468.413 | 326.735 |
Intangibles, Net | 353.676 | 337.274 | 287.1 | 212.552 | 135.438 |
Long Term Investments | |||||
Other Long Term Assets, Total | 1.655 | 2.518 | 3.054 | 3.158 | 4.529 |
Total Current Liabilities | 404.196 | 375.262 | 318.956 | 48.313 | 129.842 |
Accounts Payable | 27.554 | 36.203 | 16.88 | 11.425 | 10.489 |
Accrued Expenses | 56.335 | 63.969 | 41.598 | 28.009 | 13.551 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 35.692 | 19.832 | 16.741 | 8.879 | 2.314 |
Total Liabilities | 613.958 | 608.287 | 373.737 | 340.345 | 159.053 |
Total Long Term Debt | 0 | 0 | 0 | 232.767 | 0 |
Long Term Debt | 0 | 232.767 | 0 | ||
Other Liabilities, Total | 186.762 | 199.545 | 27.749 | 29.321 | 4.125 |
Total Equity | 1910.7 | 1750.07 | 1529.15 | 1059.77 | 615.568 |
Common Stock | 0.556 | 0.553 | 0.548 | 0.521 | 0.439 |
Additional Paid-In Capital | 1547.27 | 1572.34 | 1460.75 | 1068.43 | 642.59 |
Retained Earnings (Accumulated Deficit) | 397.272 | 194.06 | 65.769 | 5.843 | -15.568 |
Unrealized Gain (Loss) | |||||
Other Equity, Total | -34.394 | -16.886 | 2.085 | -15.027 | -11.893 |
Total Liabilities & Shareholders’ Equity | 2524.66 | 2358.35 | 1902.89 | 1400.11 | 774.621 |
Total Common Shares Outstanding | 55.5577 | 55.3215 | 54.7608 | 52.0783 | 43.9174 |
Deferred Income Tax | 23 | 33.48 | 27.032 | 29.944 | 25.086 |
Current Port. of LT Debt/Capital Leases | 284.615 | 255.258 | 243.737 | 0 | 103.488 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Totaal vlottende activa | 1018.8 | 998.118 | 953.233 | 975.995 | 944.789 |
Geldmiddelen en kortetermijnbeleggingen | 618.018 | 623.757 | 573.363 | 596.512 | 584.64 |
Geldmiddelen & Equivalenten | 516.609 | 523.458 | 573.363 | 596.512 | 584.64 |
Totale Vorderingen, Netto | 133.488 | 116.247 | 117.645 | 121.05 | 122.435 |
Accounts Receivable - Trade, Net | 133.488 | 116.247 | 117.645 | 121.05 | 122.435 |
Total Inventory | 244.704 | 238.277 | 242.695 | 239.117 | 213.775 |
Prepaid Expenses | 22.593 | 19.837 | 19.53 | 19.316 | 23.939 |
Total Assets | 2538.23 | 2524.66 | 2462.53 | 2444.92 | 2383.82 |
Property/Plant/Equipment, Total - Net | 314.502 | 315.696 | 295.777 | 289.709 | 247.377 |
Property/Plant/Equipment, Total - Gross | 414.878 | 408.003 | 379.881 | 369.111 | 322.731 |
Accumulated Depreciation, Total | -100.376 | -92.307 | -84.104 | -79.402 | -75.354 |
Goodwill, Net | 856.301 | 855.513 | 851.406 | 854.328 | 859.488 |
Intangibles, Net | 346.595 | 353.676 | 359.56 | 322.208 | 329.928 |
Other Long Term Assets, Total | 2.033 | 1.655 | 2.556 | 2.676 | 2.242 |
Total Current Liabilities | 405.321 | 404.196 | 410.696 | 423.522 | 424.333 |
Accounts Payable | 26.401 | 27.554 | 25.251 | 40.379 | 38.28 |
Accrued Expenses | 44.889 | 56.335 | 64.755 | 55.287 | 49.01 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 285.072 | 284.615 | 284.165 | 283.712 | 283.267 |
Other Current Liabilities, Total | 48.959 | 35.692 | 36.525 | 44.144 | 53.776 |
Total Liabilities | 597.742 | 613.958 | 627.423 | 639.552 | 617.423 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Deferred Income Tax | 22.05 | 23 | 23.413 | 23.651 | 25.858 |
Other Liabilities, Total | 170.371 | 186.762 | 193.314 | 192.379 | 167.232 |
Total Equity | 1940.49 | 1910.7 | 1835.11 | 1805.36 | 1766.4 |
Common Stock | 0.556 | 0.556 | 0.555 | 0.555 | 0.554 |
Additional Paid-In Capital | 1544.96 | 1547.27 | 1541.27 | 1533.76 | 1529.14 |
Retained Earnings (Accumulated Deficit) | 426.101 | 397.272 | 348.543 | 308.138 | 258.277 |
Other Equity, Total | -31.121 | -34.394 | -55.261 | -37.091 | -21.574 |
Total Liabilities & Shareholders’ Equity | 2538.23 | 2524.66 | 2462.53 | 2444.92 | 2383.82 |
Total Common Shares Outstanding | 55.6443 | 55.5577 | 55.5196 | 55.4659 | 55.4291 |
Other Current Assets, Total | |||||
Korte Termijn Investeringen | 101.409 | 100.299 |
- Jaarlijks
- Per kwartaal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Netto-inkomen/Beginsaldo | 185.959 | 128.291 | 59.926 | 21.411 | 16.617 |
Geldmiddelen uit Operationele Activiteiten | 172.083 | 119.016 | 62.625 | 67.216 | 32.77 |
Geldmiddelen uit Operationele Activiteiten | 50.985 | 38.447 | 27.067 | 20.868 | 15.778 |
Deferred Taxes | -1.352 | 6.517 | -3.992 | -0.624 | 0.071 |
Niet-Geldelijke Posten | 0.302 | 47.889 | 28.244 | 26.696 | 14.437 |
Cash Taxes Paid | 34.365 | 16.515 | 10.279 | 6.505 | 4.046 |
Veranderingen in het Operationeel Kapitaal | -63.811 | -102.128 | -48.62 | -1.135 | -14.133 |
Geldmiddelen uit Investeringsactiviteiten | -233.236 | -221.169 | -201.385 | -205.308 | -14.037 |
Kapitaaluitgaven | -88.346 | -71.276 | -26.344 | -23.154 | -12.782 |
Overige Cash Flow investeringsposten, Totaal | -144.89 | -149.893 | -175.041 | -182.154 | -1.255 |
Geldmiddelen uit Financieringsactiviteiten | -13.337 | 0.961 | 305.916 | 484.867 | 3.407 |
Financiering van Cash Flow Posten | -17.018 | -2.897 | -0.01 | -0.49 | 0 |
Uitgifte (Aflossing) van aandelen, netto | 3.707 | 3.879 | 305.926 | 321.88 | 3.418 |
Uitgifte (Aflossing) van Schulden, Netto | -0.026 | -0.021 | 0 | 163.477 | -0.011 |
Wisselkoerseffecten | -5.866 | -12.286 | 12.729 | -3.19 | -2.077 |
Nettowijziging in Geldmiddelen | -80.356 | -113.478 | 179.885 | 343.585 | 20.063 |
Contant Betaalde Rente | 1.033 | 1.066 | 1.066 | 1.484 | 2.444 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 28.829 | 185.959 | 137.23 | 96.825 | 46.964 |
Cash From Operating Activities | 11.154 | 172.083 | 110.201 | 68.834 | 23.113 |
Cash From Operating Activities | 15.252 | 50.985 | 36.605 | 23.933 | 11.834 |
Deferred Taxes | -1.124 | -1.352 | 1.722 | 0.738 | 1.045 |
Non-Cash Items | 8.089 | 0.302 | 11.02 | 6.786 | 6.029 |
Changes in Working Capital | -39.892 | -63.811 | -76.376 | -59.448 | -42.759 |
Cash From Investing Activities | -9.433 | -233.236 | -111.928 | -54.434 | -28.214 |
Capital Expenditures | -9.433 | -88.346 | -66.958 | -54.451 | -28.231 |
Other Investing Cash Flow Items, Total | 0 | -144.89 | -44.97 | 0.017 | 0.017 |
Cash From Financing Activities | -9.563 | -13.337 | -13.063 | -14.314 | -12.021 |
Financing Cash Flow Items | -9.592 | -17.018 | -15.829 | -14.759 | -12.311 |
Issuance (Retirement) of Stock, Net | 0.029 | 3.707 | 2.784 | 0.463 | 0.296 |
Issuance (Retirement) of Debt, Net | 0 | -0.026 | -0.018 | -0.018 | -0.006 |
Foreign Exchange Effects | 0.993 | -5.866 | -15.661 | -7.388 | -2.052 |
Net Change in Cash | -6.849 | -80.356 | -30.451 | -7.302 | -19.174 |
Cash Taxes Paid | |||||
Cash Interest Paid |
Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.0874 | 5059875 | -123948 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 8.8438 | 4924208 | 94772 | 2023-03-31 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 6.6801 | 3719466 | -1312459 | 2023-03-31 | LOW |
Roy T. Eddleman UEO | Individual Investor | 6.2859 | 3500000 | 3500000 | 2022-12-31 | |
Fidelity Management & Research Company LLC | Investment Advisor | 2.9922 | 1666076 | 873378 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.9394 | 1636663 | 36669 | 2023-03-31 | LOW |
Sands Capital Management, LLC | Investment Advisor | 2.9002 | 1614851 | -166588 | 2023-03-31 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 2.6824 | 1493551 | 662807 | 2023-03-31 | LOW |
Brown Capital Management, LLC | Investment Advisor | 2.5869 | 1440368 | -11967 | 2023-03-31 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 2.5629 | 1426994 | 727390 | 2023-03-31 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 2.2869 | 1273333 | -185749 | 2023-03-31 | LOW |
Artisan Partners Limited Partnership | Investment Advisor | 2.1939 | 1221581 | 53738 | 2023-03-31 | LOW |
Macquarie Investment Management | Investment Advisor | 2.032 | 1131432 | 30818 | 2023-03-31 | LOW |
Franklin Advisers, Inc. | Investment Advisor/Hedge Fund | 1.8254 | 1016387 | -47601 | 2023-03-31 | LOW |
William Blair Investment Management, LLC | Investment Advisor/Hedge Fund | 1.6368 | 911368 | 237796 | 2023-03-31 | LOW |
AllianceBernstein L.P. | Investment Advisor/Hedge Fund | 1.5671 | 872534 | -206571 | 2023-03-31 | LOW |
Impax Asset Management Ltd. | Investment Advisor | 1.556 | 866379 | 45527 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.4109 | 785602 | 25836 | 2023-03-31 | LOW |
Conestoga Capital Advisors, LLC | Investment Advisor | 1.231 | 685441 | 3623 | 2023-03-31 | LOW |
Mellon Investments Corporation | Investment Advisor/Hedge Fund | 1.1765 | 655077 | -15403 | 2023-03-31 | LOW |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com Group535K+
Handelaren
87K+
Actieve klanten per maand
$113M+
Maandelijks beleggingsvolume
$64M+
Opgenomen per maand
Handelscalculator
Bereken uw virtuele winst- en verliesrekening indien u een CFD-positie had geopend op een bepaalde datum (kies een datum) en gesloten op een andere datum (kies een datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Repligen Company profile
Over Repligen
Repligen Corporation is een biowetenschapsbedrijf dat bioprocestechnologieën en -systemen ontwikkelt en commercialiseert die de flexibiliteit verhogen in het productieproces van biologische geneesmiddelen. De bioprocessing-activiteiten van de onderneming bestaan uit vier franchises: filtratie; chromatografie; procesanalyse; en proteïnen. De Filtration-producten worden gebruikt in procesontwikkeling en productie op processchaal (klinisch en commercieel). De franchise Chromatografie omvat producten die worden gebruikt bij de downstreamzuivering, ontwikkeling en productie van biologische geneesmiddelen. De Process Analytics-producten stellen eindgebruikers in staat om in-line absorptiemetingen uit te voeren die het mogelijk maken om de eiwitconcentratie te bepalen in filtratie-, chromatografie-, formulatie- en fill-finish-toepassingen. De Eiwitten-franchise wordt vertegenwoordigd door zijn Eiwit A-affiniteits-liganden, die een essentiële component zijn van Eiwit A-chromatografieharsen die worden gebruikt in de downstreamzuivering van vrijwel alle op mAb's gebaseerde geneesmiddelen op de markt.
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
Building 1, Suite 100
41 Seyon Street
WALTHAM
MASSACHUSETTS 02453
US
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 535.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen